Email Sign-up
Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Interviews
Investigator Perspectives
Case-Based Peer Perspectives
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | 2018 SGO Annual Meeting on Women’s Cancer
Specialties >>
Acute Myeloid Leukemia
Biosimilars
Bladder Cancer
Brain Cancer
Breast Cancer
Chronic Lymphocytic Leukemia
Colorectal Cancer
Follicular Lymphoma
Gastric Cancer
Gastrointestinal Cancers
Genitourinary Cancers
Gynecologic Cancers
Head and Neck Cancers
Hematology
HER2- Breast Cancer
Immunotherapy
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
Melanoma
Multiple Myeloma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Soft Tissue Sarcoma
Partners >>
Dialogues in Diagnostics
Differential Diagnosis
Case-Based Peer Perspectives
Email Sign-Up
2016 Genitourinary Cancers Symposium
The 2016 GU Cancers Symposium, held at the Moscone West Building in San Francisco, from January 7 through 10, 2016.
Cabozantinib Bests Everolimus Across High-Risk RCC Subgroups for PFS Improvement
Jason M. Broderick
<< Prev Page
JTT Articles
Future Directions of Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer
Elevated Risk of Cardiovascular Adverse Events Identified in Meta-Analysis of Carfilzomib Studies
Model Identifies Risk of Progression in Smoldering Multiple Myeloma With Greater Precision
>> View Peer-Reviewed Articles